{"id":65340,"date":"2025-02-09T12:00:00","date_gmt":"2025-02-09T12:00:00","guid":{"rendered":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france"},"modified":"2025-02-09T12:00:00","modified_gmt":"2025-02-09T12:00:00","slug":"wegovy-offert-temporairement-a-3-000-patients-en-france","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/wegovy-offert-temporairement-a-3-000-patients-en-france","title":{"rendered":"Wegovy Offert Temporairement \u00e0 3.000 Patients en France."},"content":{"rendered":"<p><span style=\"color: #ff6600\"><strong>Africa-Press &#8211; Senegal. <\/strong><\/span>Le laboratoire danois Novo Nordisk, qui commercialise l\u2019anti-obe\u0301site\u0301 Wegovy, s\u2019est engage\u0301 a\u0300 continuer de fournir ce me\u0301dicament a\u0300 titre gracieux aux 3.000 patients actuellement traite\u0301s en France, ont annonce\u0301 lundi 3 fe\u0301vrier 2025 le ministe\u0300re de la Sante\u0301 et le groupe pharmaceutique. Cette poursuite de la prise en charge court \u00ab jusqu\u2019au 31 de\u0301cembre 2025 au plus tard, dans l\u2019attente de la ne\u0301gociation du prix pour permettre un remboursement en droit commun \u00bb du Wegovy (se\u0301maglutide), pre\u0301cisent les deux parties.<\/p>\n<p><b>\u00ab Continuite\u0301 de traitement \u00bb<\/b><\/p>\n<p>Utilise\u0301 dans la prise en charge du surpoids et de l\u2019obe\u0301site\u0301, Wegovy fait partie des analogues du GLP-1 (aGLP-1), une classe de me\u0301dicaments qui mime une hormone intestinale et stimule la se\u0301cre\u0301tion d\u2019insuline et procure une sensation de satie\u0301te\u0301. Il est commercialise\u0301 en France depuis octobre 2024 sans e\u0302tre rembourse\u0301 et son prix est fixe\u0301 librement. Mais gra\u0302ce au dispositif d\u2019acce\u0300s pre\u0301coce cre\u0301e\u0301 en juillet 2022, plusieurs milliers de patients ont eu acce\u0300s au Wegovy avant sa mise sur le marche\u0301 franc\u0327ais.<\/p>\n<p>Il est actuellement fourni a\u0300 titre gracieux par Novo Nordisk aux 3.000 patients en \u00ab continuite\u0301 de traitement \u00bb. Le laboratoire, champion mondial de l\u2019insuline, a indique\u0301 dans un message a\u0300 l\u2019AFP poursuivre \u00ab les discussions afin de permettre un acce\u0300s plus large a\u0300 Wegovy pour apporter une solution a\u0300 un plus grand nombre de patients \u00bb. \u00ab A\u0300 la suite de la re\u0301e\u0301valuation scientifique du me\u0301dicament par la Haute Autorite\u0301 de sante\u0301 (HAS) en de\u0301cembre 2024, le laboratoire souhaite de\u0301sormais ouvrir de nouvelles ne\u0301gociations tarifaires avec le CEPS (NDLR: comite\u0301 e\u0301conomique des produits de sante\u0301) dans l\u2019objectif d\u2019une inscription au remboursement \u00bb, de\u0301taille le ministe\u0300re de la Sante\u0301 dans son communique\u0301.<\/p>\n<p>La HAS a conclu de\u0301but de\u0301cembre a\u0300 un avis positif au remboursement uniquement aupre\u0300s d\u2019adultes a\u0300 l\u2019obe\u0301site\u0301 marque\u0301e et seulement apre\u0300s qu\u2019un changement de re\u0301gime alimentaire n\u2019a pas suffi a\u0300 lui seul a\u0300 une perte de poids. L\u2019obe\u0301site\u0301 touche de\u0301sormais plus d\u2019un milliard de personnes dans le monde, selon une e\u0301tude publie\u0301e en mars dans la revue me\u0301dicale britannique The Lancet. L\u2019obe\u0301site\u0301 accumule les risques de complications me\u0301taboliques, cardiovasculaires, oste\u0301oarticulaires, cancers et troubles psychologiques.<\/p>\n<p><strong>Pour plus d&rsquo;informations et d&rsquo;analyses sur la <span style=\"color: #ff6600\">Senegal<\/span>, suivez <span style=\"color: #ff6600\">Africa-Press<span style=\"color: #ff6600\"><\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Africa-Press &#8211; Senegal. Le laboratoire danois Novo Nordisk, qui commercialise l\u2019anti-obe\u0301site\u0301 Wegovy, s\u2019est engage\u0301 a\u0300 continuer de fournir ce me\u0301dicament a\u0300 titre gracieux aux 3.000 patients actuellement traite\u0301s en France, ont annonce\u0301 lundi 3 fe\u0301vrier 2025 le ministe\u0300re de la Sante\u0301 et le groupe pharmaceutique. Cette poursuite de la prise en charge court \u00ab jusqu\u2019au [&hellip;]<\/p>\n","protected":false},"author":82,"featured_media":65339,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22,10],"tags":[44],"class_list":["post-65340","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-divers","category-toutes-les-actualites","tag-senegal-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.1 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Wegovy Offert Temporairement \u00e0 3.000 Patients en France. - Senegal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wegovy Offert Temporairement \u00e0 3.000 Patients en France.\" \/>\n<meta property=\"og:description\" content=\"Africa-Press &#8211; Senegal. Le laboratoire danois Novo Nordisk, qui commercialise l\u2019anti-obe\u0301site\u0301 Wegovy, s\u2019est engage\u0301 a\u0300 continuer de fournir ce me\u0301dicament a\u0300 titre gracieux aux 3.000 patients actuellement traite\u0301s en France, ont annonce\u0301 lundi 3 fe\u0301vrier 2025 le ministe\u0300re de la Sante\u0301 et le groupe pharmaceutique. Cette poursuite de la prise en charge court \u00ab jusqu\u2019au [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france\" \/>\n<meta property=\"og:site_name\" content=\"Senegal\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-09T12:00:00+00:00\" \/>\n<meta name=\"author\" content=\"cfeditorfr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditorfr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france\"},\"author\":{\"name\":\"cfeditorfr\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"headline\":\"Wegovy Offert Temporairement \u00e0 3.000 Patients en France.\",\"datePublished\":\"2025-02-09T12:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france\"},\"wordCount\":419,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/02\/sm_1739182101.55563.jpg\",\"keywords\":[\"Senegal\"],\"articleSection\":[\"Divers\",\"Toutes les actualit\u00e9s\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france\",\"name\":\"Wegovy Offert Temporairement \u00e0 3.000 Patients en France. - Senegal\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/02\/sm_1739182101.55563.jpg\",\"datePublished\":\"2025-02-09T12:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/02\/sm_1739182101.55563.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/02\/sm_1739182101.55563.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Wegovy Offert Temporairement \u00e0 3.000 Patients en France.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.africa-press.net\/senegal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wegovy Offert Temporairement \u00e0 3.000 Patients en France.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#website\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/\",\"name\":\"Africa Press | Senegal | Homepage\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/senegal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\",\"name\":\"cfeditorfr\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/author\/cfeditorfr\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Wegovy Offert Temporairement \u00e0 3.000 Patients en France. - Senegal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france","og_locale":"fr_FR","og_type":"article","og_title":"Wegovy Offert Temporairement \u00e0 3.000 Patients en France.","og_description":"Africa-Press &#8211; Senegal. Le laboratoire danois Novo Nordisk, qui commercialise l\u2019anti-obe\u0301site\u0301 Wegovy, s\u2019est engage\u0301 a\u0300 continuer de fournir ce me\u0301dicament a\u0300 titre gracieux aux 3.000 patients actuellement traite\u0301s en France, ont annonce\u0301 lundi 3 fe\u0301vrier 2025 le ministe\u0300re de la Sante\u0301 et le groupe pharmaceutique. Cette poursuite de la prise en charge court \u00ab jusqu\u2019au [&hellip;]","og_url":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france","og_site_name":"Senegal","article_published_time":"2025-02-09T12:00:00+00:00","author":"cfeditorfr","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"cfeditorfr","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france"},"author":{"name":"cfeditorfr","@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"headline":"Wegovy Offert Temporairement \u00e0 3.000 Patients en France.","datePublished":"2025-02-09T12:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france"},"wordCount":419,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/02\/sm_1739182101.55563.jpg","keywords":["Senegal"],"articleSection":["Divers","Toutes les actualit\u00e9s"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france","url":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france","name":"Wegovy Offert Temporairement \u00e0 3.000 Patients en France. - Senegal","isPartOf":{"@id":"https:\/\/www.africa-press.net\/senegal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/02\/sm_1739182101.55563.jpg","datePublished":"2025-02-09T12:00:00+00:00","author":{"@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"breadcrumb":{"@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#primaryimage","url":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/02\/sm_1739182101.55563.jpg","contentUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2025\/02\/sm_1739182101.55563.jpg","width":1280,"height":720,"caption":"Wegovy Offert Temporairement \u00e0 3.000 Patients en France."},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/senegal\/politique\/wegovy-offert-temporairement-a-3-000-patients-en-france#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.africa-press.net\/senegal\/"},{"@type":"ListItem","position":2,"name":"Wegovy Offert Temporairement \u00e0 3.000 Patients en France."}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/senegal\/#website","url":"https:\/\/www.africa-press.net\/senegal\/","name":"Africa Press | Senegal | Homepage","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/senegal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1","name":"cfeditorfr","url":"https:\/\/www.africa-press.net\/senegal\/author\/cfeditorfr"}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts\/65340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/comments?post=65340"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts\/65340\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/media\/65339"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/media?parent=65340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/categories?post=65340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/tags?post=65340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}